Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 9, 1996, Pages 2004-2011

  Anderson, Kevin P ^a   Fox, Maureen C ^a   Brown Driver, Vickie ^a   Martin, Michael J ^a   Azad, Raana F ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; IMMEDIATE EARLY PROTEIN; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; RIBONUCLEASE H;

ANTIVIRAL ACTIVITY; ARTICLE; BASE PAIRING; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; PRIORITY JOURNAL; SKIN FIBROBLAST; VIRUS ADSORPTION; VIRUS CELL TRANSFORMATION; VIRUS INHIBITION;

EID: 0029821897     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.9.2004     Document Type: Article

References (26)

1. Anderson, K. P., R. F. Azad, H. Zhang, J. Huffman, R. Miner, and W. L. Drew. Growth inhibition of clinical and drug-resistant isolates of human cytomegalovirus by the antisense phosphorothioate oligonucleotide ISIS 2922. Unpublished data.
2. Azad, R. F., V. Brown-Driver, R. W. Buckheit, Jr., and K. P. Anderson. 1995. Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogs. Antiviral Res. 28:101-111.
3. Azad, R. F., V. B. Driver, K. Tanaka, R. M. Crooke, and K. P. Anderson. 1993. Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region. Antimicrob. Agents Chemother. 37:1945-1954.
4. Baracchini, E., E. Glezer, K. Fish, R. M. Stenberg, J. A. Nelson, and P. Ghazal. 1992. An isoform variant of the cytomegalovirus immediate-early auto repressor functions as a transcriptional activator. Virology 188:518-529.
5. Bennett, C. F., M. Chiang, H. Chan, J. E. Shoemaker, and C. K. Mirabelli. 1992. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41:1023-1033.
6. Bennett, C. F., T. P. Condon, S. Grimm, H. Chan, and M. Y. Chiang. 1994. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J. Immunol. 152:3530-3540.
7. Chee, M. S., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. Hutchison III, T. Kouzarides, J. A. Martignetti, E. Preddie, S. C. Satchwell, P. Tomlinson, K. M. Weston, and B. G. Barrell. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
8. Chiang, M. Y., H. Chan, M. A. Zounes, S. M. Freier, W. F. Lima, and C. F. Bennett. 1991. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266:18162-18171.
9. Cummins, L. L., S. R. Owens, L. M. Risen, E. A. Lesnik, S. M. Freier, D. McGee, C. J. Guinosso, and P. D. Cook. 1995. Characterization of fully 2′-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity. Nucleic Acids Res. 23:2019-2024.
10. Dean, N. M., R. McKay, T. P. Condon, and C. F. Bennett. 1994. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J. Biol. Chem. 269:16416-16424.
11. Ecker, D. J., J. R. Wyatt, and T. Vickers. 1995. Novel guanosine quartet structure binds to the HIV envelope and inhibits envelope mediated fusion. Nucleosides Nucleotides 14:1117-1127.
12. Gao, W., R. N. Hanes, M. A. Vasquez-Padua, C. A. Stein, J. S. Cohen, and Y. Cheng. 1990. Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides. Antimicrob. Agents Chemother. 34:808-812.
13. Gao, W., J. W. Jaroszewski, J. S. Cohen, and Y.-C. Cheng. 1990. Mechanisms of inhibition of herpes simplex virus type 2 growth by 28-mer phosphorothioate oligodeoxycytidine. J. Biol. Chem. 265:20172-20178.
14. Gao, W., C. A. Stein, J. S. Cohen, G. E. Dutschman, and Y.-C. Cheng. 1989. Effect of phosphorothioate homo-oligodeoxynucleotides on herpes simplex virus type 2-induced DNA polymerase. J. Biol. Chem. 264:11521-11526.
15. Hanecak, R., V. Brown-Driver, M. C. Fox, R. F. Azad, S. Furusako, C. Ford, S. R. Owens, H. Sasmor, and K. P. Anderson. 1996. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. J. Virol. 70:5203-5212.
16. Krieg, A., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (London) 374:546-549.
17. Margolis, M. J., S. Pajovic, E. L. Wong, M. Wade, R. Jupp, J. A. Nelson, and J. C. Azizkhan. 1995. Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. J. Virol. 69:7759-7767.
18. Matsukura, M., K. Shinozuka, G. Zon, H. Mitsuya, M. Reitz, J. S. Cohen, and S. Broder. 1987. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 84:7706-7710.
19. Matsukura, M., G. Zon, K. Shinozuka, M. Robert-Guroff, T. Shimada, C. A. Stein, H. Mitsuya, F. Wong-Staal, J. S. Cohen, and S. Broder. 1989. Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells. Proc. Natl. Acad. Sci. USA 86:4244-4248.
20. Miraglia, L., T. Burckin, K. P. Anderson, and B. F. Baker. Mechanistic analysis of modified antisense oligonucleotides which target the 5′ cap region of the HCMV IE72 transcript in a cell-free translation system. J. Biol. Chem., in press.
21. Monia, B. P., J. F. Johnston, D. J. Ecker, M. A. Zaunes, W. F. Lima, and S. M. Freier. 1993. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J. Biol. Chem. 267:19954-19962.
22. Rando, R. F., J. Ojwang, A. Elbaggari, G. R. Reyes, R. Tinder, M. S. McGrath, and M. E. Hogan. 1995. Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetrads. J. Biol. Chem. 270:1754-1760.
23. Stenberg, R. M., P. R. Witte, and M. F. Stinski. 1985. Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1. J. Virol. 56:665-675.
24. Vickers, T., B. F. Baker, P. D. Cook, M. Zounes, R. W. Buckheit, Jr., J. Germany, and D. J. Ecker. 1991. Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element. Nucleic Acids Res. 19:3359-3368.
25. Vickers, T., and D. J. Ecker. 1992. Enhancement of ribosomal frameshifting by oligonucleotides targeted to the HIV gag-pol region. Nucleic Acids Res. 20:3945-3953.
26. Wyatt, J. R., T. A. Vickers, J. L. Roberson, R. W. Buckheit, Jr., T. Klimkait, E. DeBaets, P. W. Davis, B. Rayner, J. L. Imbach, and D. J. Ecker. 1994. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc. Natl. Acad. Sci. USA 91:1356-1360.